Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +46.82%
#2 Purr Purr +35.45%
#3 Pons Pons +35.34%
#4 TENDIES TENDIES +31.66%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +28.83%
#6 Starpower Starpower +28.19%
#7 StonkBroker StonkBroker +25.85%
#8 SkyAI SkyAI +24.57%
#9 PondCoin PondCoin +21.91%
#10 Magma Finance Magma Finance +20.37%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
InDex Pharmaceuticals Holding AB (publ) InDex Pharmaceuticals Holding AB (publ)

InDex Pharmaceuticals Holding AB (publ)

INDEX
Kedudukan dalam Saham #28996
InDex Pharmaceuticals Holding AB (publ) is a pharmaceutical firm dedicated to... InDex Pharmaceuticals Holding AB (publ) is a pharmaceutical firm dedicated to developing therapeutic solutions for patients affected by ulcerative colitis. The company's flagship drug candidate, Cobitolimod, is presently in Phase III clinical trials, targeting the treatment of moderate to severe ulcerative colitis. Furthermore, InDex is progressing a pipeline of other DNA-based immunomodulatory sequences, which are in the preclinical phase, designed to address various immunological conditions. This enterprise was established in 2000 and operates from its headquarters in Solna, Sweden.
Harga Saham
$0.04406501
Disegerakkan terakhir: 2024-07-09
Modal Pasaran
$23.47M
Perubahan (1 hari)
-0.48%
Perubahan (1 tahun)
0.00%
Negara
SE
Perdagangan InDex Pharmaceuticals Holding AB (publ) (INDEX)

Kategori

Healthcare
Hasil untuk InDex Pharmaceuticals Holding AB (publ) (INDEX)
Hasil pada Aug 2026 TTM: 0
Menurut laporan kewangan terkini daripada InDex Pharmaceuticals Holding AB (publ), hasil semasa syarikat (TTM) ialah 0. Pada tahun 2026, syarikat memperoleh hasil sebanyak 0 sama dengan hasil pada tahun 2026 iaitu 0. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi InDex Pharmaceuticals Holding AB (publ) dari 2026 hingga 2026
Hasil pada akhir setiap tahun
Tahun Hasil Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil untuk syarikat atau pesaing serupa
Syarikat Hasil Perbezaan Hasil Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH